Eurofins Advinus has supported drug discovery research for over 15 years. As an experienced drug discovery organization, Eurofins Advinus offers a truly integrated approach for small molecule drug discovery, bringing major key disciplines under one umbrella to achieve a project goal by a single project team. We manage your project at every step of the way.
Our team has extensive experience and expertise over 35 plus targets for novel, first-in-class targets as well as fast follow-on targets, and has produced multiple assets that are in preclinical and clinical development. We are the first company from India to establish R&D alliances with companies such as Merck, J&J, Takeda, Novartis, Celgene and DNDi.
We have the capabilities and infrastructure to assist you across multiple therapeutic areas such as Oncology, Fibrosis, Inflammation & Autoimmune, CNS, Pain, Metabolic & Cardiovascular disorders, Gastrointestinal disorders, Ocular and Neglected diseases.
Our business engagement models are flexible to the needs of our customers. We value our clients and tailor our services to their needs for every step of the R&D value chain. We understand your need for the right balance of speed and cost with highest quality and endeavor to develop a partnership that creates mutual success.
Our drug discovery services include -
Medicinal Chemistry
ADMET/DMPK
Discovery Biology
Safety Pharmacology
-
Industry
-
Research
-
Company size
-
201-500 employees
-
Headquarters
-
Bangalore, KA
-
Specialties
-
medicinal chemistry, ADME, DMPK, In Vitro Biology, and Safety pharmacology